UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 110

Sortiert nach

Ovarian carcinoma pathology and genetics: recent advances

Human pathology, 2009-09, Vol.40 (9), p.1213-1223

2009

Link zum Volltext

Verfügbarkeit prüfen

Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features

Virchows Archiv : an international journal of pathology, 2012-03, Vol.460 (3), p.237-249

Prat, Jaime

2012

Link zum Volltext

Verfügbarkeit prüfen

Comparative clinicopathologic and immunohistochemical analysis of uterine sarcomas diagnosed using the World Health Organization classification system

Human pathology, 2009-11, Vol.40 (11), p.1571-1585

2009

Link zum Volltext

Verfügbarkeit prüfen

Prognostic significance of FOXL2 mutation and mRNA expression in adult and juvenile granulosa cell tumors of the ovary

Modern pathology, 2011-10, Vol.24 (10), p.1360-1367

2011

Link zum Volltext

Verfügbarkeit prüfen

Repression of E-cadherin by SNAIL, ZEB1, and TWIST in invasive ductal carcinomas of the breast: a cooperative effort?

Human pathology, 2011, Vol.42 (1), p.103-110

2011

Link zum Volltext

Verfügbarkeit prüfen

Ovarian carcinomas: at least five different diseases with distinct histological features and molecular genetics

Human pathology, 2018-10, Vol.80, p.11-27

2018

Link zum Volltext

Verfügbarkeit prüfen

The FOXO1-miR27 tandem regulates myometrial invasion in endometrioid endometrial adenocarcinoma

Human pathology, 2014-05, Vol.45 (5), p.942-951

2014

Link zum Volltext

Verfügbarkeit prüfen

CD8 down-regulation on cytotoxic T lymphocytes of patients with endometrioid endometrial carcinomas

Human pathology, 2016-10, Vol.56, p.180-188

2016

Link zum Volltext

Verfügbarkeit prüfen

Prognostic parameters of endometrial carcinoma

Human pathology, 2004-06, Vol.35 (6), p.649-662

Prat, Jaime

2004

Link zum Volltext

Verfügbarkeit prüfen

Stromal signatures in endometrioid endometrial carcinomas

Modern pathology, 2014-04, Vol.27 (4), p.631-639

2014

Link zum Volltext

Verfügbarkeit prüfen

Molecular genetic alterations in endometrioid carcinomas of the ovary: Similar frequency of beta-catenin abnormalities but lower rate of microsatellite instability and PTEN alterations than in uterine endometrioid carcinomas

Human pathology, 2004-11, Vol.35 (11), p.1360-1368

2004

Link zum Volltext

Verfügbarkeit prüfen

Promoter hypermethylation and reduced expression of RASSF1A are frequent molecular alterations of endometrial carcinoma

Modern pathology, 2008-06, Vol.21 (6), p.691-699

2008

Link zum Volltext

Verfügbarkeit prüfen

Mullerian Adenosarcoma : A Clinicopathologic and Immunohistochemical Study of 55 Cases Challenging the Existence of Adenofibroma

The American journal of surgical pathology, 2009-02, Vol.33 (2), p.278-288

2009

Link zum Volltext

Verfügbarkeit prüfen

CDC42-positive macrophages may prevent malignant transformation of ovarian endometriosis

Human pathology, 2012-05, Vol.43 (5), p.720-725

2012

Link zum Volltext

Verfügbarkeit prüfen

Molecular pathology of endometrial hyperplasia and carcinoma

Human pathology, 2001-06, Vol.32 (6), p.569-577

2001

Link zum Volltext

Verfügbarkeit prüfen

Molecular events in endometrial carcinosarcomas and the role of high mobility group AT-hook 2 in endometrial carcinogenesis

Human pathology, 2013-02, Vol.44 (2), p.244-254

2013

Link zum Volltext

Verfügbarkeit prüfen

Immunohistochemical heterogeneity of breast carcinomas negative for estrogen receptors, progesterone receptors and Her2/neu (basal-like breast carcinomas)

Modern pathology, 2007-11, Vol.20 (11), p.1200-1207

2007

Link zum Volltext

Verfügbarkeit prüfen

Serous borderline (low malignant potential, atypical proliferative) ovarian tumors: Workshop perspectives

Human pathology, 2004-08, Vol.35 (8), p.934-948

2004

Link zum Volltext

Verfügbarkeit prüfen

hMLH1 Promoter Hypermethylation Is an Early Event in Human Endometrial Tumorigenesis

The American journal of pathology, 1999-11, Vol.155 (5), p.1767-1772

1999

Link zum Volltext

Verfügbarkeit prüfen

Ovarian clear cell carcinomas: RHO GTPases may contribute to explain their singular biologic behavior

Human pathology, 2011-06, Vol.42 (6), p.833-839

2011

Link zum Volltext

Verfügbarkeit prüfen

Abnormalities of E- and P-cadherin and catenin (β-, γ-catenin, and p120ctn) expression in endometrial cancer and endometrial atypical hyperplasia

The Journal of pathology, 2003-04, Vol.199 (4), p.471-478

2003

Link zum Volltext

Verfügbarkeit prüfen

Gene expression microarray-based assay to determine tumor site of origin in a series of metastatic tumors to the ovary and peritoneal carcinomatosis of suspected gynecologic origin

Human pathology, 2013, Vol.44 (1), p.20-28

2013

Link zum Volltext

Verfügbarkeit prüfen

Concomitant PI3K-AKT and p53 alterations in endometrial carcinomas are associated with poor prognosis

Modern pathology, 2009-04, Vol.22 (4), p.522-529

2009

Link zum Volltext

Verfügbarkeit prüfen

Expression profile of heptahelical putative membrane progesterone receptors in epithelial ovarian tumors

Human pathology, 2008-07, Vol.39 (7), p.1026-1033

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 110

Suche als RSS-Feed

Aktive Filter

ThemaTumors

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(109)
Mit Volltextzugriff
(106)

Publikationsform

Artikel
(110)

Sprache

Englisch
(110)
Japanisch
(25)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(97)
Science & Technology
(97)
Humans
(96)
Female
(92)
Pathology
(79)
Biological And Medical Sciences
(78)
Medical Sciences
(77)
Gynecology. Andrology. Obstetrics
(66)
Female Genital Diseases
(64)
Middle Aged
(46)
Adult
(44)
Aged
(42)
Immunohistochemistry
(40)
Mutation
(37)
Ovarian Neoplasms - Pathology
(35)
Endometrial Neoplasms - Genetics
(28)
Aged, 80 And Over
(25)
Ovarian Neoplasms - Genetics
(25)
Investigative Techniques, Diagnostic Techniques
(24)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Ovarian carcinoma pathology and genetics: recent advances

Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features

Comparative clinicopathologic and immunohistochemical analysis of uterine sarcomas diagnosed using the World Health Organization classification system

Prognostic significance of FOXL2 mutation and mRNA expression in adult and juvenile granulosa cell tumors of the ovary

Repression of E-cadherin by SNAIL, ZEB1, and TWIST in invasive ductal carcinomas of the breast: a cooperative effort?

The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma-A Study by the Spanish Group for Ovarian Cancer Research (GEICO)

Ovarian carcinomas: at least five different diseases with distinct histological features and molecular genetics

The FOXO1-miR27 tandem regulates myometrial invasion in endometrioid endometrial adenocarcinoma

CD8 down-regulation on cytotoxic T lymphocytes of patients with endometrioid endometrial carcinomas

Prognostic parameters of endometrial carcinoma

Stromal signatures in endometrioid endometrial carcinomas

Molecular genetic alterations in endometrioid carcinomas of the ovary: Similar frequency of beta-catenin abnormalities but lower rate of microsatellite instability and PTEN alterations than in uterine endometrioid carcinomas

Promoter hypermethylation and reduced expression of RASSF1A are frequent molecular alterations of endometrial carcinoma

Mullerian Adenosarcoma : A Clinicopathologic and Immunohistochemical Study of 55 Cases Challenging the Existence of Adenofibroma

CDC42-positive macrophages may prevent malignant transformation of ovarian endometriosis

Molecular pathology of endometrial hyperplasia and carcinoma

Molecular events in endometrial carcinosarcomas and the role of high mobility group AT-hook 2 in endometrial carcinogenesis

Immunohistochemical heterogeneity of breast carcinomas negative for estrogen receptors, progesterone receptors and Her2/neu (basal-like breast carcinomas)

Serous borderline (low malignant potential, atypical proliferative) ovarian tumors: Workshop perspectives

hMLH1 Promoter Hypermethylation Is an Early Event in Human Endometrial Tumorigenesis

Ovarian clear cell carcinomas: RHO GTPases may contribute to explain their singular biologic behavior

Abnormalities of E- and P-cadherin and catenin (β-, γ-catenin, and p120ctn) expression in endometrial cancer and endometrial atypical hyperplasia

Gene expression microarray-based assay to determine tumor site of origin in a series of metastatic tumors to the ovary and peritoneal carcinomatosis of suspected gynecologic origin

Concomitant PI3K-AKT and p53 alterations in endometrial carcinomas are associated with poor prognosis

Expression profile of heptahelical putative membrane progesterone receptors in epithelial ovarian tumors

Aktive Filter

Suchergebnisse filtern